Altimmune (ALT, $6.68) was one of the top gainers yesterday, rising to $6.68 per share. A.I.dvisor analyzed 873 stocks in the Biotechnology Industry and found that of them (7) are in an Uptrend while of them (2) are in a Downtrend. A.I.dvisor found 284 similar cases when ALT's price jumped over within one day. In out of those 284 cases, ALT's price went down during the next month. Based on these historical data, A.I. thinks the odds of an Uptrend reversal for ALT are